SLS   $5.26  1.15% Market Open

SELLAS Life Sciences Group, Inc.

EMA (20): 2026-02-18 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2025-12-04 the price crossed up the moving average line and demonstrates an upside trend.

EMA (100): 2025-12-04 the price crossed up the moving average line and demonstrates a strong upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: entrance to the overbought zone.

Stochastic: The stochastic indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 47.89%
EMA (20) date of signal Feb. 18, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 222.13%
EMA (50) date of signal Dec. 4, 2025, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 222.13%
EMA (100) date of signal Dec. 4, 2025, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 13.92%
RSI (14) date of signal Feb. 26, 2026, 3 a.m.
MACD Signals bullish recovery
MACD Yield 47.89%
MACD date of signal Feb. 18, 2026, 3 a.m.
Stochastic Signals bullish recovery
Stochastic Yield 13.92%
Stochastic date of signal Feb. 26, 2026, 3 a.m.
Updated March 4, 2026, 8:52 p.m.